Return to Search
Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release (ER) and Long-Acting (LA) Opioids
Guidance for the approved Risk Evaluation and Mitigation Strategy (REMS) for extended-release (ER) and long-acting (LA) opioids.
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 14, 2014
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.